How Boards of Pharmacy Are Addressing White and Brown Bagging
Home Study Webinar $20 Activity Fee – available through June 29, 2024. Payers are increasingly requiring many clinician-administered drugs to be dispensed through specialty pharmacy-based distribution models, commonly known as white bagging and brown bagging. This home study will provide an in-depth discussion of: This home study webinar is a recording of the live activity […]
Read More ›Understanding the Updated NCPDP SCRIPT National E-prescribing Standard
Home Study Webinar $20 Activity Fee – available through August 5, 2024. The National Council for Prescription Drug Programs (NCPDP) SCRIPT standard was created to allow the electronic transfer of prescription information between pharmacists and prescribers in the United States. The Medicare Modernization Act, which implemented Medicare Part D, requires that HHS determine the e-prescribing standard used for […]
Read More ›DSCSA Update – What Do Regulators and Pharmacies Really Need to Know?
Home Study Webinar Free Activity – available through March 28, 2026. On August 28, 2023, FDA announced that it would delay enforcement of certain provisions of DSCSA until November 27, 2024. The FDA guidance offers more details. Although November 2023 appears to be off in the distant future, there is much for the pharmacy community to do to […]
Read More ›Compounding From BDS: Understanding FDA’s Final Guidance
Home Study Webinar Free Activity – available through March 28, 2026. This presentation is an overview of FDA’s Guidance for Industry #256, “Compounding Animal Drugs from Bulk Drug Substances.” The guidance is intended for veterinarians, state-licensed pharmacies, and federal facilities interested in compounding animal drugs from bulk drug substances for use in nonfood-producing animals, as antidotes […]
Read More ›The Importance of CAG 003 to the Successful Certification of Sterile Compounding Environments
Home Study Webinar $20 Activity Fee – available through February 28, 2026. With the long-anticipated changes to USP General Chapter <797>, one unexpected change was the removal of the reference to CETA Application Guide (CAG) 003. This document, published by the Controlled Environment Testing Association (CETA), is a compilation of all the testing required to […]
Read More ›Workplace Conditions and Pharmacy Personnel Burnout – Changing Course to Advance Change
Home Study Webinar $20 Activity Fee – available through April 9, 2025 Pharmacist workload, burnout, and well-being issues, and their effect on patient safety, have been considered for years, but the coronavirus disease 2019 pandemic has brought such concerns to the forefront. The concerns brought by various pharmacy groups regarding workplace conditions and how they affect […]
Read More ›The Evolving Overdose Crisis: Opportunities for Action
Home Study Webinar $20 Activity Fee – available through April 9, 2025 This session will delve into the current opioid epidemic landscape, how far we have come, and what is still needed in furtherance of public health protection. Experts will discuss the trends and opportunities that exist regarding prevention and harm reduction, such as the new […]
Read More ›Pharmacy Technicians: Expanding Scope Is Key to Advancing Practice
Home Study Webinar $20 Activity Fee – available through April 9, 2025 There is no doubt that expanding the scope of practice for pharmacy technicians is key to supporting pharmacists, including alleviating their dispensing responsibilities, so that pharmacists may assume a more clinical role in providing patient care. Whereas one can say that coronavirus disease 2019 […]
Read More ›Understanding New DSCSA Requirements and Common Diversion Schemes
Home Study Webinar Free Activity – available through February 1, 2025. This webinar will discuss the timeline for the implementation of the Drug Supply Chain Security Act (DSCSA) requirements and how regulations will be impacted. Review findings from NABP’s Drug Distributor Accreditation and OTC Medical Device Distributor Accreditation programs, including instances of counterfeit drugs and distribution inconsistencies in the supply […]
Read More ›